mirvetuximab soravtansine
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of mirvetuximab soravtansine injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Mirvetuximab soravtansine orders must be signed by a Hematology/Oncology/Gynecology-Oncology Attending Physician
Med Center UNC Medical Center Formulary Restrictions
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of mirvetuximab soravtansine injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Mirvetuximab soravtansine orders must be signed by a Hematology/Oncology/Gynecology-Oncology Attending Physician
Med Center
UNC Medical Center Formulary Restrictions